---
schema_version: "secwatch.filing_event.v1"
accession: "0001740797-25-000020"
form_type: "8-K"
ticker: "AVAI"
cik: "0001740797"
company_name: "AVAI BIO, INC."
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T02:21:04.288974+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avant Technologies expands joint venture territory to global license; extends conditions deadline to Nov 2025

## Summary
- Addendum expands Ainnova’s Technology Portfolio license to global territory (previously North America and Europe).
- Conditions satisfaction deadline under Joint Venture Agreement extended from May 8, 2025 to November 8, 2025.
- Parties agree to possible merger terms as per Term Sheet signed September 21, 2024.
- Ai-nova Acquisition Corp, LLC formed December 6, 2024; jointly represented by CEOs of Avant and Ainnova.

## SEC filing metadata
- accession: 0001740797-25-000020
- form_type: 8-K
- ticker: AVAI
- cik: 0001740797
- company_name: AVAI BIO, INC.
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740797/000174079725000020/0001740797-25-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740797/000174079725000020/avai_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001740797-25-000020
- JSON: https://secwatch.observer/filing/0001740797-25-000020.json
- Plain text: https://secwatch.observer/filing/0001740797-25-000020.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.